Please login to the form below

Not currently logged in
Email:
Password:

Minoryx Therapeutics adds to board of directors

Dr Claude Nicaise joins as an independent board member

Minoryx Therapeutics Dr Claude NicaiseDr Claude Nicaise has joined Barcelona, Spain-based Minoryx Therapeutics as an independent board member.

He brings over 30 years of regulatory strategy expertise to the orphan diseases specialist, and currently also serves as a board member at Sarepta Therapeutics.

Dr Nicaise founded Clinical Regulatory Services, a biotech-focused advisory service, in 2014, having previously served as senior vice president of strategic development and global regulatory affairs at Alexion Pharmaceuticals from 2008.

Prior to this, Dr Nicaise was vice president of development at Bristol-Myers Squibb, having held a series of regulatory and project leadership positions since joining as director of clinical cancer research in 1984.

Khalid Islam, chairman of the board at Minoryx Therapeutics, said: “We are delighted to have Dr Nicaise join us as an independent board member.

“Claude's perspective, based on his distinguished career and leadership roles in R&D organisations, will be very valuable to the board as the company continues its on-going evolution.”

10th February 2017

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

How ‘Greenwashing’ accusations could delay the very changes its supporters demand
Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
What does the future hold for clinical trial recruitment?
The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...